Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Food Safety News (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

FDA’s draft guidance on allergen labeling met with lukewarm reception from consumer group

% of readers think this story is Fact. Add your two cents.


In announcing a draft compliance guide for FDA staff on enforcement about major food allergen labeling the agency has missed the mark with a comment about sesame activities, according to the Center for Science in the Public Interest.

An aside in the announcement about the guidance about allergen labeling, the Food and Drug Administration says that it “is aware that some manufacturers are intentionally adding sesame to products that previously did not contain sesame and are labeling the products to indicate its presence. . . The FDA recognizes that this practice may make it more difficult for sesame-allergic consumers to find foods that are safe for them to consume-an outcome that the FDA does not support.”

The Center for Science in the Public Interest (CPSI) is less than impressed with the FDA’s efforts, according to a statement put out by the consumer advocacy group.

“The Center for Science in the Public Interest petitioned the agency in January to prohibit companies from adding sesame and other major allergens as a way to avoid the careful cleaning and processing steps needed to prevent cross-contamination. CSPI argues that the practice, which elevates risks for consumers, violates federal requirements to mitigate allergen risks.”

The FDA states that while it’s draft guidance does not specifically address the industry’s new practice of adding sesame to products that previously did not contain it, the guidance does address the FDA’s enforcement policy for labeling and cross-contact controls for major food allergens, including sesame. The agency is “engaged with various stakeholders on this issue,” according to its announcement.

Calling the FDA’s response to the sesame situation “tepid,” the CSPI took the FDA to task.

“A lukewarm statement like this is simply not adequate,” the CSPI countered. “Companies are playing games with the rules designed to protect us, and it’s causing harm. The very least the agency could do is warn that this practice raises risks for consumers, and actively oppose it.” 

The CSPI contends that in the absence of firmer steps industry will interpret the draft guidance as a green light for further additions of sesame to the food supply, simultaneously reducing consumer choice and increase the risk of serious allergic reactions. “Industry will continue to decide that it’s cheaper and easier to add major allergens to foods, rather than actually prevent contamination risks.” 

The FDA’s announcement presents its main point of the draft guidance document to regard enforcement policy about major food allergen labeling and cross-contact, which leads to cross-contamination of non-allergic foods with the list of major allergens. That list is milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame.

“Among the updates, the draft (guidance) describes the labeling requirements for major food allergens and the proper use of the ingredient list and the ‘Contains’ statement for major food allergen declarations. It also describes requirements for firms to implement controls to prevent or significantly minimize allergen cross-contact,” according to FDA officials.

In addition to informing FDA staff, the draft guidance also describes requirements for firms to implement controls to prevent or significantly minimize allergen cross-contact. 

The draft guidance also describes additional allergen labeling violations. It directs FDA staff to examine potential product adulteration from allergen cross-contact as well as potential labeling violations.

To ensure that comments are received before work begins on the final version of the guidance, consumers and industry and other interested parties may submit electronic or written comments within 60 days of publication in the Federal Register. Submit electronic comments to http://www.regulations.gov. All comments should be identified with the docket number FDA-2023-D-1103. Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.

(To sign up for a free subscription to Food Safety News,click here)


Source: https://www.foodsafetynews.com/2023/05/fdas-draft-guidance-on-allergen-labeling-met-with-lukewarm-reception-from-consumer-group/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.